Tirzepatide 20mg
$205.00
Description
Tirzepatide is a prescription medication used to treat type 2 diabetes, manage chronic weight loss (in adults with obesity or those overweight with at least one weight-related condition), and treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. It is the active ingredient in the brand-name drugs Mounjaro (for diabetes) and Zepbound (for weight management and OSA), manufactured by Eli Lilly.
How It Works
Tirzepatide is a “first-in-class” dual agonist that mimics two natural gut hormones:
- Glucose-dependent insulinotropic polypeptide (GIP).
- Glucagon-like peptide-1 (GLP-1).
By activating the receptors for both hormones, tirzepatide works in several ways:
- It stimulates the pancreas to release more insulin when blood sugar levels are high.
- It reduces the amount of sugar produced by the liver.
- It slows down gastric emptying, which helps patients feel fuller for longer periods.
- It targets areas in the brain that regulate appetite, which can help reduce food cravings and “food noise” (constant thoughts about eating).
Administration and Dosage
Tirzepatide is administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm. The dosage typically starts low (2.5 mg) and is gradually increased by a healthcare provider every four weeks based on the patient’s tolerance and response, up to a maximum dose of 15 mg weekly.
Leave a customer review
Related products
-
Tirzepatide 5mg
$75.00 -
Retatrutide 10mg
$135.00 -
Tirzepatide 10mg
$125.00 -
AOD-9604 -10mg
$85.00
Reviews
There are no reviews yet.